GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Betaferon® | Betaseron® | Extavia® | IFNb1b
                                 IFN-β1b (recombinant human) is an approved drug (FDA (1993), EMA (1995)) Compound class: 
                                                            Peptide
                                 
                                    
                                        Comment: Compared to the sequence of endogenous IFN-β, IFN-β1b has a Ser to Cys substitution at position 17, but does not retain the glycosylation site at Asn80. It also lacks the initiating Met. This recombinant peptide is produced in E.coli.
                                    
                                 | 
For advanced searching click here to open chemical structure editor
| Other Similar Sequences  | |
| IFN-β {Sp: Human} | TargetsInterferon-α/β receptor; interferon α/β receptor 1 | 
| peginterferon beta-1a | |
| IFN-β1a (recombinant human) | |
| SNG001 | |